期刊
STEM CELLS
卷 39, 期 7, 页码 838-852出版社
OXFORD UNIV PRESS
DOI: 10.1002/stem.3357
关键词
cellular therapy; diabetes; immunotherapy; mesenchymal stromal cells; secretome
资金
- National Key Research and Development Program of China [2017YFA0104900]
- Xi'an fourth hospital incubation fund project [2019FZ46]
Type 2 diabetes mellitus (T2DM) poses a major threat to global public health, with immune dysfunction recognized as a crucial contributor to its pathogenesis. Mesenchymal stromal cells (MSCs) have emerged as promising therapeutic agents for T2DM, with their immunomodulatory effects mediated through paracrine mechanisms and extracellular vesicles (EVs). Preclinical studies have shown the benefits of MSCs in improving islet function and insulin resistance, while clinical trials have further supported their therapeutic potential for T2DM.
Type 2 diabetes mellitus (T2DM) is a major threat to global public health, with increasing prevalence as well as high morbidity and mortality, to which immune dysfunction has been recognized as a crucial contributor. Mesenchymal stromal cells (MSCs), obtained from various sources and possessing potent immunomodulatory abilities, have displayed great therapeutic potential for T2DM. Interestingly, the immunomodulatory capabilities of MSCs are endowed and plastic. Among the multiple mechanisms involved in MSC-mediated immune regulation, the paracrine effects of MSCs have attracted much attention. Of note, extracellular vesicles (EVs), an important component of MSC secretome, have emerged as pivotal mediators of their immunoregulatory effects. Particularly, the necrobiology of MSCs, especially apoptosis, has recently been revealed to affect their immunomodulatory functions in vivo. In specific, a variety of preclinical studies have demonstrated the beneficial effects of MSCs on improving islet function and ameliorating insulin resistance. More importantly, clinical trials have further uncovered the therapeutic potential of MSCs for T2DM. In this review, we outline current knowledge regarding the plasticity and underlying mechanisms of MSC-mediated immune modulation, focusing on the paracrine effects. We also summarize the applications of MSC-based therapies for T2DM in both preclinical studies and clinical trials, with particular emphasis on the modulation of immune system.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据